Bio-Rad Laboratories (BIO) came out with quarterly earnings of $3.31 per share, missing the Zacks Consensus Estimate of $3.45 per share. This compares to earnings of $3.21 per share a year ago. These ...
The market didn't react positively to the diagnostics specialist's third-quarter earnings report. It beat on both the top and bottom lines, but growth rates were low. Bio-Rad's Q3 saw the company book ...
May 7 (Reuters) - Diagnostics firm Bio Rad Laboratories (BIO.N), opens new tab reiterated its 2024 sales growth forecast on Tuesday, weighed by persistently weak spending by biotech companies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback